{"id":347771,"date":"2025-08-25T12:54:57","date_gmt":"2025-08-25T12:54:57","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-ultragenyx-pharmaceutical\/"},"modified":"2025-08-25T12:54:57","modified_gmt":"2025-08-25T12:54:57","slug":"how-to-buy-ultragenyx-pharmaceutical","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334090,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-347771","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE), bao g\u1ed3m ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, quy tr\u00ecnh mua t\u1eebng b\u01b0\u1edbc v\u00e0 nh\u1eefng nh\u1eadn \u0111\u1ecbnh chuy\u00ean gia v\u1ec1 c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ea7y tri\u1ec3n v\u1ecdng n\u00e0y.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE), bao g\u1ed3m ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, quy tr\u00ecnh mua t\u1eebng b\u01b0\u1edbc v\u00e0 nh\u1eefng nh\u1eadn \u0111\u1ecbnh chuy\u00ean gia v\u1ec1 c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ea7y tri\u1ec3n v\u1ecdng n\u00e0y."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o li\u1ec7u ph\u00e1p gen ti\u00ean ti\u1ebfn? Ultragenyx Pharmaceutical Inc. (RARE) \u0111\u1ea1i di\u1ec7n cho ranh gi\u1edbi \u0111\u1ea7y h\u1ee9ng kh\u1edfi trong ph\u00e1t tri\u1ec3n \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh hi\u1ebfm g\u1eb7p. C\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc s\u00e1ng t\u1ea1o n\u00e0y \u0111ang t\u1ea1o d\u1ea5u \u1ea5n v\u1edbi danh m\u1ee5c s\u1ea3n ph\u1ea9m ti\u00ean ti\u1ebfn v\u00e0 c\u00e1c c\u1ed9t m\u1ed1c ph\u00e1p l\u00fd g\u1ea7n \u0111\u00e2y. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 l\u00fd do t\u1ea1i sao c\u1ed5 phi\u1ebfu RARE x\u1ee9ng \u0111\u00e1ng \u0111\u01b0\u1ee3c ch\u00fa \u00fd v\u00e0 c\u00e1ch b\u1ea1n c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh m\u1ed9t ph\u1ea7n c\u1ee7a cu\u1ed9c c\u00e1ch m\u1ea1ng y h\u1ecdc n\u00e0y.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o li\u1ec7u ph\u00e1p gen ti\u00ean ti\u1ebfn? Ultragenyx Pharmaceutical Inc. (RARE) \u0111\u1ea1i di\u1ec7n cho ranh gi\u1edbi \u0111\u1ea7y h\u1ee9ng kh\u1edfi trong ph\u00e1t tri\u1ec3n \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh hi\u1ebfm g\u1eb7p. C\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc s\u00e1ng t\u1ea1o n\u00e0y \u0111ang t\u1ea1o d\u1ea5u \u1ea5n v\u1edbi danh m\u1ee5c s\u1ea3n ph\u1ea9m ti\u00ean ti\u1ebfn v\u00e0 c\u00e1c c\u1ed9t m\u1ed1c ph\u00e1p l\u00fd g\u1ea7n \u0111\u00e2y. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 l\u00fd do t\u1ea1i sao c\u1ed5 phi\u1ebfu RARE x\u1ee9ng \u0111\u00e1ng \u0111\u01b0\u1ee3c ch\u00fa \u00fd v\u00e0 c\u00e1ch b\u1ea1n c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh m\u1ed9t ph\u1ea7n c\u1ee7a cu\u1ed9c c\u00e1ch m\u1ea1ng y h\u1ecdc n\u00e0y."},"body_html":"<h2>\ud83d\udcc8 Hi\u1ec7u Su\u1ea5t C\u1ed5 Phi\u1ebfu Hi\u1ec7n T\u1ea1i v\u00e0 V\u1ecb Th\u1ebf Th\u1ecb Tr\u01b0\u1eddng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, Ultragenyx Pharmaceutical Inc. (RARE) \u0111ang giao d\u1ecbch \u1edf m\u1ee9c <strong>29,78 USD<\/strong> m\u1ed7i c\u1ed5 phi\u1ebfu. C\u00f4ng ty \u0111\u00e3 tr\u1ea3i qua bi\u1ebfn \u0111\u1ed9ng \u0111\u00e1ng k\u1ec3 trong s\u00e1u th\u00e1ng qua, v\u1edbi gi\u00e1 dao \u0111\u1ed9ng t\u1eeb m\u1ee9c cao g\u1ea7n 36,52 USD v\u00e0o cu\u1ed1i th\u00e1ng 6 \u0111\u1ebfn m\u1ee9c hi\u1ec7n t\u1ea1i, t\u01b0\u01a1ng \u0111\u01b0\u01a1ng gi\u1ea3m kho\u1ea3ng 20%.<\/p> <p><strong>\u0110\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: ng\u00e0y 4 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng \u0111\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 RARE. \u0110\u00f3 l\u00e0 khi c\u00f4ng ty c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c th\u00f4ng b\u00e1o n\u00e0y th\u01b0\u1eddng t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3.<\/p> <h3>C\u00e1ch B\u00e1o C\u00e1o L\u1ee3i Nhu\u1eadn \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu RARE<\/h3> <p>Xem x\u00e9t l\u1ecbch s\u1eed g\u1ea7n \u0111\u00e2y, ch\u00fang ta c\u00f3 th\u1ec3 th\u1ea5y m\u1ed9t m\u00f4 h\u00ecnh r\u00f5 r\u00e0ng:<\/p> <ul> <li><strong>Ng\u00e0y 5 th\u00e1ng 8 n\u0103m 2025<\/strong>: B\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 2 v\u1edbi EPS l\u00e0 -1,17 USD (v\u01b0\u1ee3t \u01b0\u1edbc t\u00ednh 0,10 USD) v\u00e0 doanh thu 166,50 tri\u1ec7u USD (t\u0103ng 13,2% so v\u1edbi c\u00f9ng k\u1ef3 n\u0103m tr\u01b0\u1edbc). M\u1eb7c d\u00f9 v\u01b0\u1ee3t k\u1ef3 v\u1ecdng, c\u1ed5 phi\u1ebfu \u0111\u00e3 gi\u1ea3m t\u1eeb m\u1ee9c tr\u01b0\u1edbc b\u00e1o c\u00e1o kho\u1ea3ng 32 USD xu\u1ed1ng c\u00f2n kho\u1ea3ng 29,78 USD hi\u1ec7n t\u1ea1i.<\/li> <li><strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: L\u1ee3i nhu\u1eadn qu\u00fd 1 cho th\u1ea5y doanh thu 139 tri\u1ec7u USD (t\u0103ng 28%) nh\u01b0ng c\u1ed5 phi\u1ebfu v\u1eabn bi\u1ebfn \u0111\u1ed9ng do c\u00e1c m\u1ed1i quan ng\u1ea1i v\u1ec1 quy \u0111\u1ecbnh \u0111ang di\u1ec5n ra.<\/li> <\/ul> <p>M\u00f4 h\u00ecnh n\u00e0y cho th\u1ea5y m\u1eb7c d\u00f9 Ultragenyx li\u00ean t\u1ee5c v\u01b0\u1ee3t k\u1ef3 v\u1ecdng doanh thu, c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 v\u1eabn th\u1eadn tr\u1ecdng v\u1ec1 con \u0111\u01b0\u1eddng \u0111\u1ea1t l\u1ee3i nhu\u1eadn v\u00e0 c\u00e1c r\u00e0o c\u1ea3n ph\u00e1p l\u00fd c\u1ee7a c\u00f4ng ty.<\/p> <h3>Ph\u00e2n T\u00edch H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng<\/h3> <p>T\u1eeb th\u00e1ng 2 \u0111\u1ebfn th\u00e1ng 8 n\u0103m 2025, c\u1ed5 phi\u1ebfu RARE \u0111\u00e3 tr\u1ea3i qua nhi\u1ec1u bi\u1ebfn \u0111\u1ed9ng:<\/p> <p><strong>Th\u00e1ng 2 n\u0103m 2025<\/strong>: Giao d\u1ecbch quanh m\u1ee9c 32-35 USD khi nh\u00e0 \u0111\u1ea7u t\u01b0 ch\u1edd \u0111\u1ee3i k\u1ebft qu\u1ea3 qu\u00fd 4 n\u0103m 2024<br> <strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: Gi\u1ea3m xu\u1ed1ng kho\u1ea3ng 28-30 USD gi\u1eefa nh\u1eefng lo ng\u1ea1i chung c\u1ee7a ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<br> <strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: Ph\u1ee5c h\u1ed3i l\u00ean 34-36 USD sau t\u0103ng tr\u01b0\u1edfng doanh thu qu\u00fd 1 m\u1ea1nh 28%<br> <strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: \u0110\u1ea1t \u0111\u1ec9nh g\u1ea7n 36,52 USD khi s\u1ef1 l\u1ea1c quan t\u0103ng l\u00ean v\u1ec1 ti\u1ebfn tri\u1ec3n danh m\u1ee5c s\u1ea3n ph\u1ea9m<br> <strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: Gi\u1ea3m xu\u1ed1ng 29-31 USD sau th\u01b0 ph\u1ea3n h\u1ed3i ho\u00e0n ch\u1ec9nh c\u1ee7a FDA cho UX111<br> <strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: \u1ed4n \u0111\u1ecbnh quanh m\u1ee9c 29-30 USD m\u1eb7c d\u00f9 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 2 t\u00edch c\u1ef1c<\/p> <p>Xu h\u01b0\u1edbng t\u1ed5ng th\u1ec3 cho th\u1ea5y c\u00f4ng ty \u0111ang \u0111\u1ed1i m\u1eb7t v\u1edbi c\u1ea3 c\u01a1 h\u1ed9i l\u1edbn v\u00e0 th\u00e1ch th\u1ee9c \u0111\u00e1ng k\u1ec3, t\u1ea1o ra s\u1ef1 bi\u1ebfn \u0111\u1ed9ng m\u00e0 c\u00e1c nh\u00e0 giao d\u1ecbch th\u00f4ng minh c\u00f3 th\u1ec3 t\u1eadn d\u1ee5ng.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <p>D\u1ef1a tr\u00ean nghi\u00ean c\u1ee9u to\u00e0n di\u1ec7n c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u00e0 c\u00e1c ph\u00e1t tri\u1ec3n trong danh m\u1ee5c hi\u1ec7n t\u1ea1i, \u0111\u00e2y l\u00e0 d\u1ef1 b\u00e1o c\u1ee7a c\u00e1c chuy\u00ean gia:<\/p> <p><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: M\u1ee9c 48-55 USD (+60-85% so v\u1edbi m\u1ee9c hi\u1ec7n t\u1ea1i) - <strong>MUA<\/strong> khuy\u1ebfn ngh\u1ecb<br> S\u1ef1 k\u1ebft h\u1ee3p c\u1ee7a t\u0103ng tr\u01b0\u1edfng doanh thu qu\u00fd 3\/qu\u00fd 4 d\u1ef1 ki\u1ebfn v\u00e0 ti\u1ebfn tri\u1ec3n ph\u00e1p l\u00fd ti\u1ec1m n\u0103ng h\u1ed7 tr\u1ee3 tri\u1ec3n v\u1ecdng l\u1ea1c quan n\u00e0y.<\/p> <p><strong>D\u1ef1 b\u00e1o n\u0103m 2026<\/strong>: M\u1ee9c 65-75 USD<br> Nhi\u1ec1u nh\u00e0 ph\u00e2n t\u00edch d\u1ef1 b\u00e1o \"\u0111i\u1ec3m ngo\u1eb7t doanh thu l\u1edbn\" v\u00e0o n\u0103m 2026 khi c\u00e1c li\u1ec7u ph\u00e1p m\u1edbi c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0 b\u1eaft \u0111\u1ea7u \u0111\u00f3ng g\u00f3p \u0111\u00e1ng k\u1ec3 v\u00e0o doanh thu.<\/p> <p><strong>D\u1ef1 b\u00e1o n\u0103m 2028<\/strong>: M\u1ee9c 85-100+ USD<br> V\u1edbi s\u00e1u li\u1ec7u ph\u00e1p b\u1ed5 sung d\u1ef1 ki\u1ebfn \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0o cu\u1ed1i n\u0103m 2028 theo ph\u00e2n t\u00edch c\u1ee7a William Blair, c\u01a1 s\u1edf doanh thu c\u00f3 th\u1ec3 m\u1edf r\u1ed9ng \u0111\u00e1ng k\u1ec3.<\/p> <p><strong>T\u1ea7m nh\u00ecn n\u0103m 2030<\/strong>: Ti\u1ec1m n\u0103ng 120-150+ USD<br> C\u00e1c nh\u00e0 ph\u00e2n t\u00edch d\u00e0i h\u1ea1n d\u1ef1 b\u00e1o c\u00e1c s\u1ea3n ph\u1ea9m \u0111\u1ed9t ph\u00e1 nh\u01b0 setrusumab c\u00f3 th\u1ec3 t\u1ea1o ra doanh thu \u0111\u1ec9nh \u0111i\u1ec3m 2,4 t\u1ef7 USD v\u00e0o n\u0103m 2037, v\u1edbi Ultragenyx chi\u1ebfm kho\u1ea3ng 1,4 t\u1ef7 USD trong gi\u00e1 tr\u1ecb \u0111\u00f3.<\/p> <p>\u0110\u1ed3ng thu\u1eadn c\u1ee7a 21 c\u00f4ng ty m\u00f4i gi\u1edbi l\u00e0 r\u1ea5t t\u00edch c\u1ef1c, v\u1edbi khuy\u1ebfn ngh\u1ecb trung b\u00ecnh 1,7 (tr\u1ea1ng th\u00e1i \"V\u01b0\u1ee3t tr\u1ed9i\") v\u00e0 m\u1ee5c ti\u00eau gi\u00e1 dao \u0111\u1ed9ng t\u1eeb 39 \u0111\u1ebfn 136 USD.<\/p> <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i Ro C\u1ea7n Xem X\u00e9t<\/h3> <ul> <li><strong>Th\u00e1ch Th\u1ee9c Ph\u00e1p L\u00fd<\/strong>: Th\u01b0 ph\u1ea3n h\u1ed3i ho\u00e0n ch\u1ec9nh c\u1ee7a FDA v\u00e0o th\u00e1ng 7 n\u0103m 2025 cho UX111 \u0111\u00e3 l\u00e0m n\u1ed5i b\u1eadt c\u00e1c v\u1ea5n \u0111\u1ec1 v\u1ec1 s\u1ea3n xu\u1ea5t v\u00e0 ki\u1ec3m so\u00e1t ch\u1ea5t l\u01b0\u1ee3ng c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn c\u00e1c s\u1ea3n ph\u1ea9m kh\u00e1c trong danh m\u1ee5c.<\/li> <li><strong>Kh\u1ea3 N\u0103ng T\u00e0i Ch\u00ednh B\u1ec1n V\u1eefng<\/strong>: M\u1eb7c d\u00f9 t\u0103ng tr\u01b0\u1edfng doanh thu 28% trong qu\u00fd 1 n\u0103m 2025, c\u00f4ng ty b\u00e1o c\u00e1o l\u1ed7 r\u00f2ng l\u1edbn 569 tri\u1ec7u USD n\u0103m 2024. Con \u0111\u01b0\u1eddng \u0111\u1ebfn l\u1ee3i nhu\u1eadn v\u1eabn ch\u01b0a r\u00f5 r\u00e0ng.<\/li> <li><strong>Bi\u1ebfn \u0110\u1ed9ng Cao<\/strong>: V\u1edbi bi\u1ebfn \u0111\u1ed9ng gi\u00e1 trung b\u00ecnh h\u00e0ng ng\u00e0y 4,31%, RARE kh\u00f4ng d\u00e0nh cho nh\u00e0 \u0111\u1ea7u t\u01b0 ng\u1ea1i r\u1ee7i ro. Ph\u1ea1m vi 52 tu\u1ea7n t\u1eeb 25,81 \u0111\u1ebfn 60,37 USD cho th\u1ea5y s\u1ef1 bi\u1ebfn \u0111\u1ed9ng c\u1ef1c \u0111oan.<\/li> <li><strong>Ph\u1ee5 Thu\u1ed9c V\u00e0o Danh M\u1ee5c<\/strong>: Gi\u00e1 tr\u1ecb c\u00f4ng ty ph\u1ee5 thu\u1ed9c nhi\u1ec1u v\u00e0o vi\u1ec7c ph\u00ea duy\u1ec7t th\u00e0nh c\u00f4ng c\u00e1c li\u1ec7u ph\u00e1p gen \u0111ang ph\u00e1t tri\u1ec3n.<\/li> <\/ul> <h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho 2025-2026<\/h3> <ul> <li><strong>T\u0103ng Tr\u01b0\u1edfng Doanh Thu M\u1ea1nh M\u1ebd<\/strong>: Doanh thu qu\u00fd 2 n\u0103m 2025 \u0111\u1ea1t 166,50 tri\u1ec7u USD, t\u0103ng 13,2% so v\u1edbi c\u00f9ng k\u1ef3 n\u0103m tr\u01b0\u1edbc, v\u01b0\u1ee3t k\u1ef3 v\u1ecdng c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch.<\/li> <li><strong>Ti\u1ebfn Tr\u00ecnh BLA DTX401<\/strong>: Vi\u1ec7c b\u1eaft \u0111\u1ea7u n\u1ed9p h\u1ed3 s\u01a1 BLA theo d\u1ea1ng cu\u1ed9n cho li\u1ec7u ph\u00e1p gen DTX401 v\u00e0o ng\u00e0y 18 th\u00e1ng 8 n\u0103m 2025 l\u00e0 m\u1ed9t c\u1ed9t m\u1ed1c ph\u00e1p l\u00fd quan tr\u1ecdng (<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/18\/3134959\/0\/en\/Ultragenyx-Initiates-Rolling-Submission-of-Biologics-License-Application-BLA-to-U-S-FDA-for-DTX401-AAV-Gene-Therapy-for-the-Treatment-of-Glycogen-Storage-Disease-Type-Ia-GSDIa.html\">Th\u00f4ng b\u00e1o ch\u00ednh th\u1ee9c<\/a>).<\/li> <li><strong>Ni\u1ec1m Tin C\u1ee7a Nh\u00e0 Ph\u00e2n T\u00edch<\/strong>: 20 trong s\u1ed1 21 nh\u00e0 ph\u00e2n t\u00edch \u0111\u00e1nh gi\u00e1 RARE l\u00e0 Mua ho\u1eb7c Mua M\u1ea1nh, v\u1edbi m\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh cho th\u1ea5y ti\u1ec1m n\u0103ng t\u0103ng tr\u00ean 190%.<\/li> <li><strong>V\u1ecb Th\u1ebf Th\u1ecb Tr\u01b0\u1eddng<\/strong>: Ultragenyx t\u1eadp trung v\u00e0o c\u00e1c b\u1ec7nh hi\u1ebfm g\u1eb7p v\u1edbi nhu c\u1ea7u y t\u1ebf ch\u01b0a \u0111\u01b0\u1ee3c \u0111\u00e1p \u1ee9ng l\u1edbn, t\u1ea1o ti\u1ec1m n\u0103ng cho gi\u00e1 cao c\u1ea5p v\u00e0 s\u1ef1 ch\u1ea5p nh\u1eadn nhanh ch\u00f3ng khi \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t.<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <p>D\u1ef1a tr\u00ean ph\u00e2n t\u00edch t\u00ecnh h\u00ecnh hi\u1ec7n t\u1ea1i, \u0111\u00e2y l\u00e0 l\u1eddi khuy\u00ean c\u1ee7a t\u00f4i:<\/p> <ul> <li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: Do bi\u1ebfn \u0111\u1ed9ng cao, h\u00e3y b\u1eaft \u0111\u1ea7u v\u1edbi v\u1ecb th\u1ebf kh\u00f4ng qu\u00e1 2-3% t\u1ed5ng danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n. \u0110i\u1ec1u n\u00e0y gi\u00fap b\u1ea1n t\u1eadn d\u1ee5ng \u0111\u01b0\u1ee3c l\u1ee3i th\u1ebf t\u0103ng gi\u00e1 trong khi h\u1ea1n ch\u1ebf r\u1ee7i ro gi\u1ea3m gi\u00e1.<\/li> <li><strong>Trung b\u00ecnh gi\u00e1 mua<\/strong>: Thay v\u00ec mua m\u1ed9t l\u1ea7n, h\u00e3y c\u00e2n nh\u1eafc mua c\u1ed5 phi\u1ebfu trong v\u00e0i tu\u1ea7n \u0111\u1ec3 trung b\u00ecnh gi\u00e1 v\u00e0o gi\u1eefa bi\u1ebfn \u0111\u1ed9ng.<\/li> <li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/strong>: Theo d\u00f5i c\u00e1c m\u1ee9c quan tr\u1ecdng - 27,20 USD l\u00e0 h\u1ed7 tr\u1ee3 m\u1ea1nh, trong khi v\u01b0\u1ee3t tr\u00ean 32 USD c\u00f3 th\u1ec3 b\u00e1o hi\u1ec7u \u0111\u00e0 t\u0103ng m\u1edbi.<\/li> <li><strong>Lu\u00f4n c\u1eadp nh\u1eadt<\/strong>: \u0110\u00e1nh d\u1ea5u ng\u00e0y 4 th\u00e1ng 11 tr\u00ean l\u1ecbch cho b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3 v\u00e0 theo d\u00f5i c\u00e1c c\u1eadp nh\u1eadt c\u1ee7a FDA v\u1ec1 vi\u1ec7c ho\u00e0n th\u00e0nh BLA DTX401 d\u1ef1 ki\u1ebfn trong qu\u00fd 4 n\u0103m 2025.<\/li> <li><strong>Ch\u00e2m ng\u00f4n h\u00e0i h\u01b0\u1edbc c\u1ee7a ng\u01b0\u1eddi k\u1ef3 c\u1ef1u<\/strong>: \"Giao d\u1ecbch c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc nh\u01b0 RARE gi\u1ed1ng nh\u01b0 th\u1ef1c hi\u1ec7n li\u1ec7u ph\u00e1p gen - b\u1ea1n c\u1ea7n \u0111\u00f4i tay v\u1eefng, ki\u00ean nh\u1eabn qua bi\u1ebfn \u0111\u1ed9ng v\u00e0 ni\u1ec1m tin r\u1eb1ng nghi\u00ean c\u1ee9u h\u00f4m nay s\u1ebd l\u00e0 ph\u00e9p m\u00e0u ng\u00e0y mai. Ch\u1ec9 \u0111\u1eebng c\u1ed1 g\u1eafng gh\u00e9p ADN danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n m\u00e0 kh\u00f4ng qu\u1ea3n l\u00fd r\u1ee7i ro \u0111\u00fang c\u00e1ch!\"<\/li> <\/ul> <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td><td>Ch\u1ecdn nh\u00e0 m\u00f4i gi\u1edbi cung c\u1ea5p danh s\u00e1ch NASDAQ v\u00e0 m\u1ee9c ph\u00ed hoa h\u1ed3ng c\u1ea1nh tranh<\/td><\/tr> <tr><td>2<\/td><td>M\u1edf v\u00e0 n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i khi r\u1ee7i ro do bi\u1ebfn \u0111\u1ed9ng c\u1ee7a RARE<\/td><\/tr> <tr><td>3<\/td><td>Nghi\u00ean c\u1ee9u gi\u00e1 hi\u1ec7n t\u1ea1i<\/td><td>Ki\u1ec3m tra b\u00e1o gi\u00e1 th\u1eddi gian th\u1ef1c - RARE giao d\u1ecbch tr\u00ean NASDAQ v\u1edbi m\u00e3 \"RARE\"<\/td><\/tr> <tr><td>4<\/td><td>\u0110\u1eb7t l\u1ec7nh mua<\/td><td>S\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o thay v\u00ec l\u1ec7nh th\u1ecb tr\u01b0\u1eddng<\/td><\/tr> <tr><td>5<\/td><td>Gi\u00e1m s\u00e1t kho\u1ea3n \u0111\u1ea7u t\u01b0<\/td><td>\u0110\u1eb7t c\u1ea3nh b\u00e1o cho ng\u00e0y c\u00f4ng b\u1ed1 l\u1ee3i nhu\u1eadn v\u00e0 c\u00e1c m\u1ee9c gi\u00e1 quan tr\u1ecdng do c\u1ed5 phi\u1ebfu nh\u1ea1y c\u1ea3m v\u1edbi tin t\u1ee9c<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Thu H\u00fat Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2> <p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi mu\u1ed1n b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0 v\u1edbi Ultragenyx Pharmaceutical, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf ph\u00f9 h\u1ee3p v\u1edbi nh\u00e0 giao d\u1ecbch m\u1edbi:<\/p> <ul> <li><strong>D\u1ec5 ti\u1ebfp c\u1eadn<\/strong>: V\u1edbi s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD, b\u1ea1n c\u00f3 th\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u00e0 t\u00edch l\u0169y kinh nghi\u1ec7m m\u00e0 kh\u00f4ng c\u1ea7n cam k\u1ebft t\u00e0i ch\u00ednh l\u1edbn.<\/li> <li><strong>Quy tr\u00ecnh \u0111\u01a1n gi\u1ea3n<\/strong>: X\u00e1c minh KYC trong 1 ph\u00fat ch\u1ec9 v\u1edbi m\u1ed9t gi\u1ea5y t\u1edd duy nh\u1ea5t gi\u00fap b\u1ea1n c\u00f3 th\u1ec3 b\u1eaft \u0111\u1ea7u giao d\u1ecbch g\u1ea7n nh\u01b0 ngay l\u1eadp t\u1ee9c sau khi t\u1ea1o t\u00e0i kho\u1ea3n.<\/li> <li><strong>T\u00f9y ch\u1ecdn linh ho\u1ea1t<\/strong>: H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n mang l\u1ea1i s\u1ef1 ti\u1ec7n l\u1ee3i d\u00f9 b\u1ea1n th\u00edch ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed hay c\u00e1c ph\u01b0\u01a1ng th\u1ee9c ng\u00e2n h\u00e0ng truy\u1ec1n th\u1ed1ng.<\/li> <\/ul> <p>Giao di\u1ec7n th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng c\u00f9ng v\u1edbi r\u00e0o c\u1ea3n gia nh\u1eadp th\u1ea5p khi\u1ebfn \u0111\u00e2y l\u00e0 l\u1ef1a ch\u1ecdn tuy\u1ec7t v\u1eddi cho nh\u00e0 \u0111\u1ea7u t\u01b0 mu\u1ed1n ti\u1ebfp c\u1eadn c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc h\u1ea5p d\u1eabn nh\u01b0 RARE m\u00e0 kh\u00f4ng ph\u1ea3i \u0111\u1ed1i m\u1eb7t v\u1edbi s\u1ef1 ph\u1ee9c t\u1ea1p c\u1ee7a c\u00e1c t\u00e0i kho\u1ea3n m\u00f4i gi\u1edbi truy\u1ec1n th\u1ed1ng.<\/p> <h2>\ud83c\udf0d Ultragenyx N\u0103m 2025: Ti\u00ean Phong Trong \u0110i\u1ec1u Tr\u1ecb B\u1ec7nh Hi\u1ebfm<\/h2> <p>Ultragenyx Pharmaceutical \u0111\u1ee9ng \u1edf v\u1ecb tr\u00ed h\u00e0ng \u0111\u1ea7u trong y h\u1ecdc di truy\u1ec1n, chuy\u00ean ph\u00e1t tri\u1ec3n c\u00e1c li\u1ec7u ph\u00e1p cho c\u00e1c b\u1ec7nh di truy\u1ec1n hi\u1ebfm v\u00e0 c\u1ef1c hi\u1ebfm. C\u00e1c s\u1ea3n ph\u1ea9m th\u01b0\u01a1ng m\u1ea1i hi\u1ec7n t\u1ea1i c\u1ee7a c\u00f4ng ty bao g\u1ed3m Crysvita\u00ae cho b\u1ec7nh h\u1ea1 phosphat huy\u1ebft li\u00ean k\u1ebft X, \u0111\u00e3 t\u1ea1o ra 103 tri\u1ec7u USD doanh thu ch\u1ec9 trong qu\u00fd 1 n\u0103m 2025.<\/p> <p>Danh m\u1ee5c s\u1ea3n ph\u1ea9m c\u1ee7a c\u00f4ng ty bao g\u1ed3m nhi\u1ec1u li\u1ec7u ph\u00e1p \u0111ang nghi\u00ean c\u1ee9u nh\u1eafm v\u00e0o c\u00e1c b\u1ec7nh nh\u01b0 h\u1ed9i ch\u1ee9ng Sanfilippo, h\u1ed9i ch\u1ee9ng Angelman v\u00e0 b\u1ec7nh d\u1ef1 tr\u1eef glycogen lo\u1ea1i Ia. Ph\u01b0\u01a1ng ph\u00e1p c\u1ee7a h\u1ecd k\u1ebft h\u1ee3p chuy\u00ean m\u00f4n khoa h\u1ecdc s\u00e2u s\u1eafc v\u1edbi s\u1ef1 t\u1eadp trung nh\u00e2n v\u0103n v\u00e0o c\u00e1c b\u1ec7nh \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn nh\u00f3m b\u1ec7nh nh\u00e2n nh\u1ecf nh\u01b0ng c\u00f3 nhu c\u1ea7u y t\u1ebf ch\u01b0a \u0111\u01b0\u1ee3c \u0111\u00e1p \u1ee9ng l\u1edbn.<\/p> <p><strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb n\u0103m 2025<\/strong>: Ultragenyx \u0111\u00e3 g\u00e2y ch\u00fa \u00fd khi c\u00f4ng b\u1ed1 r\u1eb1ng b\u1ec7nh nh\u00e2n \u0111i\u1ec1u tr\u1ecb v\u1edbi DTX401 trong c\u00e1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng \u0111\u00e3 gi\u1ea3m \u0111\u00e1ng k\u1ec3 nhu c\u1ea7u tinh b\u1ed9t ng\u00f4 (60-64%) \u0111\u1ebfn m\u1ee9c m\u1ed9t s\u1ed1 ng\u01b0\u1eddi c\u00f3 th\u1ec3 t\u1eadn h\u01b0\u1edfng gi\u1ea5c ng\u1ee7 li\u00ean t\u1ee5c \u0111\u1ea7u ti\u00ean trong nhi\u1ec1u n\u0103m - m\u1ed9t k\u1ebft qu\u1ea3 \u0111\u01a1n gi\u1ea3n nh\u01b0ng thay \u0111\u1ed5i cu\u1ed9c s\u1ed1ng \u0111\u1ed1i v\u1edbi ng\u01b0\u1eddi m\u1eafc b\u1ec7nh d\u1ef1 tr\u1eef glycogen.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Hi\u1ec7u Su\u1ea5t C\u1ed5 Phi\u1ebfu Hi\u1ec7n T\u1ea1i v\u00e0 V\u1ecb Th\u1ebf Th\u1ecb Tr\u01b0\u1eddng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, Ultragenyx Pharmaceutical Inc. (RARE) \u0111ang giao d\u1ecbch \u1edf m\u1ee9c <strong>29,78 USD<\/strong> m\u1ed7i c\u1ed5 phi\u1ebfu. C\u00f4ng ty \u0111\u00e3 tr\u1ea3i qua bi\u1ebfn \u0111\u1ed9ng \u0111\u00e1ng k\u1ec3 trong s\u00e1u th\u00e1ng qua, v\u1edbi gi\u00e1 dao \u0111\u1ed9ng t\u1eeb m\u1ee9c cao g\u1ea7n 36,52 USD v\u00e0o cu\u1ed1i th\u00e1ng 6 \u0111\u1ebfn m\u1ee9c hi\u1ec7n t\u1ea1i, t\u01b0\u01a1ng \u0111\u01b0\u01a1ng gi\u1ea3m kho\u1ea3ng 20%.<\/p>\n<p><strong>\u0110\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: ng\u00e0y 4 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng \u0111\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 RARE. \u0110\u00f3 l\u00e0 khi c\u00f4ng ty c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c th\u00f4ng b\u00e1o n\u00e0y th\u01b0\u1eddng t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3.<\/p>\n<h3>C\u00e1ch B\u00e1o C\u00e1o L\u1ee3i Nhu\u1eadn \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu RARE<\/h3>\n<p>Xem x\u00e9t l\u1ecbch s\u1eed g\u1ea7n \u0111\u00e2y, ch\u00fang ta c\u00f3 th\u1ec3 th\u1ea5y m\u1ed9t m\u00f4 h\u00ecnh r\u00f5 r\u00e0ng:<\/p>\n<ul>\n<li><strong>Ng\u00e0y 5 th\u00e1ng 8 n\u0103m 2025<\/strong>: B\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 2 v\u1edbi EPS l\u00e0 -1,17 USD (v\u01b0\u1ee3t \u01b0\u1edbc t\u00ednh 0,10 USD) v\u00e0 doanh thu 166,50 tri\u1ec7u USD (t\u0103ng 13,2% so v\u1edbi c\u00f9ng k\u1ef3 n\u0103m tr\u01b0\u1edbc). M\u1eb7c d\u00f9 v\u01b0\u1ee3t k\u1ef3 v\u1ecdng, c\u1ed5 phi\u1ebfu \u0111\u00e3 gi\u1ea3m t\u1eeb m\u1ee9c tr\u01b0\u1edbc b\u00e1o c\u00e1o kho\u1ea3ng 32 USD xu\u1ed1ng c\u00f2n kho\u1ea3ng 29,78 USD hi\u1ec7n t\u1ea1i.<\/li>\n<li><strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: L\u1ee3i nhu\u1eadn qu\u00fd 1 cho th\u1ea5y doanh thu 139 tri\u1ec7u USD (t\u0103ng 28%) nh\u01b0ng c\u1ed5 phi\u1ebfu v\u1eabn bi\u1ebfn \u0111\u1ed9ng do c\u00e1c m\u1ed1i quan ng\u1ea1i v\u1ec1 quy \u0111\u1ecbnh \u0111ang di\u1ec5n ra.<\/li>\n<\/ul>\n<p>M\u00f4 h\u00ecnh n\u00e0y cho th\u1ea5y m\u1eb7c d\u00f9 Ultragenyx li\u00ean t\u1ee5c v\u01b0\u1ee3t k\u1ef3 v\u1ecdng doanh thu, c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 v\u1eabn th\u1eadn tr\u1ecdng v\u1ec1 con \u0111\u01b0\u1eddng \u0111\u1ea1t l\u1ee3i nhu\u1eadn v\u00e0 c\u00e1c r\u00e0o c\u1ea3n ph\u00e1p l\u00fd c\u1ee7a c\u00f4ng ty.<\/p>\n<h3>Ph\u00e2n T\u00edch H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng<\/h3>\n<p>T\u1eeb th\u00e1ng 2 \u0111\u1ebfn th\u00e1ng 8 n\u0103m 2025, c\u1ed5 phi\u1ebfu RARE \u0111\u00e3 tr\u1ea3i qua nhi\u1ec1u bi\u1ebfn \u0111\u1ed9ng:<\/p>\n<p><strong>Th\u00e1ng 2 n\u0103m 2025<\/strong>: Giao d\u1ecbch quanh m\u1ee9c 32-35 USD khi nh\u00e0 \u0111\u1ea7u t\u01b0 ch\u1edd \u0111\u1ee3i k\u1ebft qu\u1ea3 qu\u00fd 4 n\u0103m 2024<br \/> <strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: Gi\u1ea3m xu\u1ed1ng kho\u1ea3ng 28-30 USD gi\u1eefa nh\u1eefng lo ng\u1ea1i chung c\u1ee7a ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<br \/> <strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: Ph\u1ee5c h\u1ed3i l\u00ean 34-36 USD sau t\u0103ng tr\u01b0\u1edfng doanh thu qu\u00fd 1 m\u1ea1nh 28%<br \/> <strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: \u0110\u1ea1t \u0111\u1ec9nh g\u1ea7n 36,52 USD khi s\u1ef1 l\u1ea1c quan t\u0103ng l\u00ean v\u1ec1 ti\u1ebfn tri\u1ec3n danh m\u1ee5c s\u1ea3n ph\u1ea9m<br \/> <strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: Gi\u1ea3m xu\u1ed1ng 29-31 USD sau th\u01b0 ph\u1ea3n h\u1ed3i ho\u00e0n ch\u1ec9nh c\u1ee7a FDA cho UX111<br \/> <strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: \u1ed4n \u0111\u1ecbnh quanh m\u1ee9c 29-30 USD m\u1eb7c d\u00f9 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 2 t\u00edch c\u1ef1c<\/p>\n<p>Xu h\u01b0\u1edbng t\u1ed5ng th\u1ec3 cho th\u1ea5y c\u00f4ng ty \u0111ang \u0111\u1ed1i m\u1eb7t v\u1edbi c\u1ea3 c\u01a1 h\u1ed9i l\u1edbn v\u00e0 th\u00e1ch th\u1ee9c \u0111\u00e1ng k\u1ec3, t\u1ea1o ra s\u1ef1 bi\u1ebfn \u0111\u1ed9ng m\u00e0 c\u00e1c nh\u00e0 giao d\u1ecbch th\u00f4ng minh c\u00f3 th\u1ec3 t\u1eadn d\u1ee5ng.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<p>D\u1ef1a tr\u00ean nghi\u00ean c\u1ee9u to\u00e0n di\u1ec7n c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u00e0 c\u00e1c ph\u00e1t tri\u1ec3n trong danh m\u1ee5c hi\u1ec7n t\u1ea1i, \u0111\u00e2y l\u00e0 d\u1ef1 b\u00e1o c\u1ee7a c\u00e1c chuy\u00ean gia:<\/p>\n<p><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: M\u1ee9c 48-55 USD (+60-85% so v\u1edbi m\u1ee9c hi\u1ec7n t\u1ea1i) &#8211; <strong>MUA<\/strong> khuy\u1ebfn ngh\u1ecb<br \/> S\u1ef1 k\u1ebft h\u1ee3p c\u1ee7a t\u0103ng tr\u01b0\u1edfng doanh thu qu\u00fd 3\/qu\u00fd 4 d\u1ef1 ki\u1ebfn v\u00e0 ti\u1ebfn tri\u1ec3n ph\u00e1p l\u00fd ti\u1ec1m n\u0103ng h\u1ed7 tr\u1ee3 tri\u1ec3n v\u1ecdng l\u1ea1c quan n\u00e0y.<\/p>\n<p><strong>D\u1ef1 b\u00e1o n\u0103m 2026<\/strong>: M\u1ee9c 65-75 USD<br \/> Nhi\u1ec1u nh\u00e0 ph\u00e2n t\u00edch d\u1ef1 b\u00e1o &#8220;\u0111i\u1ec3m ngo\u1eb7t doanh thu l\u1edbn&#8221; v\u00e0o n\u0103m 2026 khi c\u00e1c li\u1ec7u ph\u00e1p m\u1edbi c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0 b\u1eaft \u0111\u1ea7u \u0111\u00f3ng g\u00f3p \u0111\u00e1ng k\u1ec3 v\u00e0o doanh thu.<\/p>\n<p><strong>D\u1ef1 b\u00e1o n\u0103m 2028<\/strong>: M\u1ee9c 85-100+ USD<br \/> V\u1edbi s\u00e1u li\u1ec7u ph\u00e1p b\u1ed5 sung d\u1ef1 ki\u1ebfn \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0o cu\u1ed1i n\u0103m 2028 theo ph\u00e2n t\u00edch c\u1ee7a William Blair, c\u01a1 s\u1edf doanh thu c\u00f3 th\u1ec3 m\u1edf r\u1ed9ng \u0111\u00e1ng k\u1ec3.<\/p>\n<p><strong>T\u1ea7m nh\u00ecn n\u0103m 2030<\/strong>: Ti\u1ec1m n\u0103ng 120-150+ USD<br \/> C\u00e1c nh\u00e0 ph\u00e2n t\u00edch d\u00e0i h\u1ea1n d\u1ef1 b\u00e1o c\u00e1c s\u1ea3n ph\u1ea9m \u0111\u1ed9t ph\u00e1 nh\u01b0 setrusumab c\u00f3 th\u1ec3 t\u1ea1o ra doanh thu \u0111\u1ec9nh \u0111i\u1ec3m 2,4 t\u1ef7 USD v\u00e0o n\u0103m 2037, v\u1edbi Ultragenyx chi\u1ebfm kho\u1ea3ng 1,4 t\u1ef7 USD trong gi\u00e1 tr\u1ecb \u0111\u00f3.<\/p>\n<p>\u0110\u1ed3ng thu\u1eadn c\u1ee7a 21 c\u00f4ng ty m\u00f4i gi\u1edbi l\u00e0 r\u1ea5t t\u00edch c\u1ef1c, v\u1edbi khuy\u1ebfn ngh\u1ecb trung b\u00ecnh 1,7 (tr\u1ea1ng th\u00e1i &#8220;V\u01b0\u1ee3t tr\u1ed9i&#8221;) v\u00e0 m\u1ee5c ti\u00eau gi\u00e1 dao \u0111\u1ed9ng t\u1eeb 39 \u0111\u1ebfn 136 USD.<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i Ro C\u1ea7n Xem X\u00e9t<\/h3>\n<ul>\n<li><strong>Th\u00e1ch Th\u1ee9c Ph\u00e1p L\u00fd<\/strong>: Th\u01b0 ph\u1ea3n h\u1ed3i ho\u00e0n ch\u1ec9nh c\u1ee7a FDA v\u00e0o th\u00e1ng 7 n\u0103m 2025 cho UX111 \u0111\u00e3 l\u00e0m n\u1ed5i b\u1eadt c\u00e1c v\u1ea5n \u0111\u1ec1 v\u1ec1 s\u1ea3n xu\u1ea5t v\u00e0 ki\u1ec3m so\u00e1t ch\u1ea5t l\u01b0\u1ee3ng c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn c\u00e1c s\u1ea3n ph\u1ea9m kh\u00e1c trong danh m\u1ee5c.<\/li>\n<li><strong>Kh\u1ea3 N\u0103ng T\u00e0i Ch\u00ednh B\u1ec1n V\u1eefng<\/strong>: M\u1eb7c d\u00f9 t\u0103ng tr\u01b0\u1edfng doanh thu 28% trong qu\u00fd 1 n\u0103m 2025, c\u00f4ng ty b\u00e1o c\u00e1o l\u1ed7 r\u00f2ng l\u1edbn 569 tri\u1ec7u USD n\u0103m 2024. Con \u0111\u01b0\u1eddng \u0111\u1ebfn l\u1ee3i nhu\u1eadn v\u1eabn ch\u01b0a r\u00f5 r\u00e0ng.<\/li>\n<li><strong>Bi\u1ebfn \u0110\u1ed9ng Cao<\/strong>: V\u1edbi bi\u1ebfn \u0111\u1ed9ng gi\u00e1 trung b\u00ecnh h\u00e0ng ng\u00e0y 4,31%, RARE kh\u00f4ng d\u00e0nh cho nh\u00e0 \u0111\u1ea7u t\u01b0 ng\u1ea1i r\u1ee7i ro. Ph\u1ea1m vi 52 tu\u1ea7n t\u1eeb 25,81 \u0111\u1ebfn 60,37 USD cho th\u1ea5y s\u1ef1 bi\u1ebfn \u0111\u1ed9ng c\u1ef1c \u0111oan.<\/li>\n<li><strong>Ph\u1ee5 Thu\u1ed9c V\u00e0o Danh M\u1ee5c<\/strong>: Gi\u00e1 tr\u1ecb c\u00f4ng ty ph\u1ee5 thu\u1ed9c nhi\u1ec1u v\u00e0o vi\u1ec7c ph\u00ea duy\u1ec7t th\u00e0nh c\u00f4ng c\u00e1c li\u1ec7u ph\u00e1p gen \u0111ang ph\u00e1t tri\u1ec3n.<\/li>\n<\/ul>\n<h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho 2025-2026<\/h3>\n<ul>\n<li><strong>T\u0103ng Tr\u01b0\u1edfng Doanh Thu M\u1ea1nh M\u1ebd<\/strong>: Doanh thu qu\u00fd 2 n\u0103m 2025 \u0111\u1ea1t 166,50 tri\u1ec7u USD, t\u0103ng 13,2% so v\u1edbi c\u00f9ng k\u1ef3 n\u0103m tr\u01b0\u1edbc, v\u01b0\u1ee3t k\u1ef3 v\u1ecdng c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch.<\/li>\n<li><strong>Ti\u1ebfn Tr\u00ecnh BLA DTX401<\/strong>: Vi\u1ec7c b\u1eaft \u0111\u1ea7u n\u1ed9p h\u1ed3 s\u01a1 BLA theo d\u1ea1ng cu\u1ed9n cho li\u1ec7u ph\u00e1p gen DTX401 v\u00e0o ng\u00e0y 18 th\u00e1ng 8 n\u0103m 2025 l\u00e0 m\u1ed9t c\u1ed9t m\u1ed1c ph\u00e1p l\u00fd quan tr\u1ecdng (<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/18\/3134959\/0\/en\/Ultragenyx-Initiates-Rolling-Submission-of-Biologics-License-Application-BLA-to-U-S-FDA-for-DTX401-AAV-Gene-Therapy-for-the-Treatment-of-Glycogen-Storage-Disease-Type-Ia-GSDIa.html\">Th\u00f4ng b\u00e1o ch\u00ednh th\u1ee9c<\/a>).<\/li>\n<li><strong>Ni\u1ec1m Tin C\u1ee7a Nh\u00e0 Ph\u00e2n T\u00edch<\/strong>: 20 trong s\u1ed1 21 nh\u00e0 ph\u00e2n t\u00edch \u0111\u00e1nh gi\u00e1 RARE l\u00e0 Mua ho\u1eb7c Mua M\u1ea1nh, v\u1edbi m\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh cho th\u1ea5y ti\u1ec1m n\u0103ng t\u0103ng tr\u00ean 190%.<\/li>\n<li><strong>V\u1ecb Th\u1ebf Th\u1ecb Tr\u01b0\u1eddng<\/strong>: Ultragenyx t\u1eadp trung v\u00e0o c\u00e1c b\u1ec7nh hi\u1ebfm g\u1eb7p v\u1edbi nhu c\u1ea7u y t\u1ebf ch\u01b0a \u0111\u01b0\u1ee3c \u0111\u00e1p \u1ee9ng l\u1edbn, t\u1ea1o ti\u1ec1m n\u0103ng cho gi\u00e1 cao c\u1ea5p v\u00e0 s\u1ef1 ch\u1ea5p nh\u1eadn nhanh ch\u00f3ng khi \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t.<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<p>D\u1ef1a tr\u00ean ph\u00e2n t\u00edch t\u00ecnh h\u00ecnh hi\u1ec7n t\u1ea1i, \u0111\u00e2y l\u00e0 l\u1eddi khuy\u00ean c\u1ee7a t\u00f4i:<\/p>\n<ul>\n<li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: Do bi\u1ebfn \u0111\u1ed9ng cao, h\u00e3y b\u1eaft \u0111\u1ea7u v\u1edbi v\u1ecb th\u1ebf kh\u00f4ng qu\u00e1 2-3% t\u1ed5ng danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n. \u0110i\u1ec1u n\u00e0y gi\u00fap b\u1ea1n t\u1eadn d\u1ee5ng \u0111\u01b0\u1ee3c l\u1ee3i th\u1ebf t\u0103ng gi\u00e1 trong khi h\u1ea1n ch\u1ebf r\u1ee7i ro gi\u1ea3m gi\u00e1.<\/li>\n<li><strong>Trung b\u00ecnh gi\u00e1 mua<\/strong>: Thay v\u00ec mua m\u1ed9t l\u1ea7n, h\u00e3y c\u00e2n nh\u1eafc mua c\u1ed5 phi\u1ebfu trong v\u00e0i tu\u1ea7n \u0111\u1ec3 trung b\u00ecnh gi\u00e1 v\u00e0o gi\u1eefa bi\u1ebfn \u0111\u1ed9ng.<\/li>\n<li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/strong>: Theo d\u00f5i c\u00e1c m\u1ee9c quan tr\u1ecdng &#8211; 27,20 USD l\u00e0 h\u1ed7 tr\u1ee3 m\u1ea1nh, trong khi v\u01b0\u1ee3t tr\u00ean 32 USD c\u00f3 th\u1ec3 b\u00e1o hi\u1ec7u \u0111\u00e0 t\u0103ng m\u1edbi.<\/li>\n<li><strong>Lu\u00f4n c\u1eadp nh\u1eadt<\/strong>: \u0110\u00e1nh d\u1ea5u ng\u00e0y 4 th\u00e1ng 11 tr\u00ean l\u1ecbch cho b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3 v\u00e0 theo d\u00f5i c\u00e1c c\u1eadp nh\u1eadt c\u1ee7a FDA v\u1ec1 vi\u1ec7c ho\u00e0n th\u00e0nh BLA DTX401 d\u1ef1 ki\u1ebfn trong qu\u00fd 4 n\u0103m 2025.<\/li>\n<li><strong>Ch\u00e2m ng\u00f4n h\u00e0i h\u01b0\u1edbc c\u1ee7a ng\u01b0\u1eddi k\u1ef3 c\u1ef1u<\/strong>: &#8220;Giao d\u1ecbch c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc nh\u01b0 RARE gi\u1ed1ng nh\u01b0 th\u1ef1c hi\u1ec7n li\u1ec7u ph\u00e1p gen &#8211; b\u1ea1n c\u1ea7n \u0111\u00f4i tay v\u1eefng, ki\u00ean nh\u1eabn qua bi\u1ebfn \u0111\u1ed9ng v\u00e0 ni\u1ec1m tin r\u1eb1ng nghi\u00ean c\u1ee9u h\u00f4m nay s\u1ebd l\u00e0 ph\u00e9p m\u00e0u ng\u00e0y mai. Ch\u1ec9 \u0111\u1eebng c\u1ed1 g\u1eafng gh\u00e9p ADN danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n m\u00e0 kh\u00f4ng qu\u1ea3n l\u00fd r\u1ee7i ro \u0111\u00fang c\u00e1ch!&#8221;<\/li>\n<\/ul>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td>\n<td>Ch\u1ecdn nh\u00e0 m\u00f4i gi\u1edbi cung c\u1ea5p danh s\u00e1ch NASDAQ v\u00e0 m\u1ee9c ph\u00ed hoa h\u1ed3ng c\u1ea1nh tranh<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>M\u1edf v\u00e0 n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i khi r\u1ee7i ro do bi\u1ebfn \u0111\u1ed9ng c\u1ee7a RARE<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Nghi\u00ean c\u1ee9u gi\u00e1 hi\u1ec7n t\u1ea1i<\/td>\n<td>Ki\u1ec3m tra b\u00e1o gi\u00e1 th\u1eddi gian th\u1ef1c &#8211; RARE giao d\u1ecbch tr\u00ean NASDAQ v\u1edbi m\u00e3 &#8220;RARE&#8221;<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>\u0110\u1eb7t l\u1ec7nh mua<\/td>\n<td>S\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o thay v\u00ec l\u1ec7nh th\u1ecb tr\u01b0\u1eddng<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Gi\u00e1m s\u00e1t kho\u1ea3n \u0111\u1ea7u t\u01b0<\/td>\n<td>\u0110\u1eb7t c\u1ea3nh b\u00e1o cho ng\u00e0y c\u00f4ng b\u1ed1 l\u1ee3i nhu\u1eadn v\u00e0 c\u00e1c m\u1ee9c gi\u00e1 quan tr\u1ecdng do c\u1ed5 phi\u1ebfu nh\u1ea1y c\u1ea3m v\u1edbi tin t\u1ee9c<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Thu H\u00fat Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2>\n<p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi mu\u1ed1n b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0 v\u1edbi Ultragenyx Pharmaceutical, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf ph\u00f9 h\u1ee3p v\u1edbi nh\u00e0 giao d\u1ecbch m\u1edbi:<\/p>\n<ul>\n<li><strong>D\u1ec5 ti\u1ebfp c\u1eadn<\/strong>: V\u1edbi s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD, b\u1ea1n c\u00f3 th\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u00e0 t\u00edch l\u0169y kinh nghi\u1ec7m m\u00e0 kh\u00f4ng c\u1ea7n cam k\u1ebft t\u00e0i ch\u00ednh l\u1edbn.<\/li>\n<li><strong>Quy tr\u00ecnh \u0111\u01a1n gi\u1ea3n<\/strong>: X\u00e1c minh KYC trong 1 ph\u00fat ch\u1ec9 v\u1edbi m\u1ed9t gi\u1ea5y t\u1edd duy nh\u1ea5t gi\u00fap b\u1ea1n c\u00f3 th\u1ec3 b\u1eaft \u0111\u1ea7u giao d\u1ecbch g\u1ea7n nh\u01b0 ngay l\u1eadp t\u1ee9c sau khi t\u1ea1o t\u00e0i kho\u1ea3n.<\/li>\n<li><strong>T\u00f9y ch\u1ecdn linh ho\u1ea1t<\/strong>: H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n mang l\u1ea1i s\u1ef1 ti\u1ec7n l\u1ee3i d\u00f9 b\u1ea1n th\u00edch ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed hay c\u00e1c ph\u01b0\u01a1ng th\u1ee9c ng\u00e2n h\u00e0ng truy\u1ec1n th\u1ed1ng.<\/li>\n<\/ul>\n<p>Giao di\u1ec7n th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng c\u00f9ng v\u1edbi r\u00e0o c\u1ea3n gia nh\u1eadp th\u1ea5p khi\u1ebfn \u0111\u00e2y l\u00e0 l\u1ef1a ch\u1ecdn tuy\u1ec7t v\u1eddi cho nh\u00e0 \u0111\u1ea7u t\u01b0 mu\u1ed1n ti\u1ebfp c\u1eadn c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc h\u1ea5p d\u1eabn nh\u01b0 RARE m\u00e0 kh\u00f4ng ph\u1ea3i \u0111\u1ed1i m\u1eb7t v\u1edbi s\u1ef1 ph\u1ee9c t\u1ea1p c\u1ee7a c\u00e1c t\u00e0i kho\u1ea3n m\u00f4i gi\u1edbi truy\u1ec1n th\u1ed1ng.<\/p>\n<h2>\ud83c\udf0d Ultragenyx N\u0103m 2025: Ti\u00ean Phong Trong \u0110i\u1ec1u Tr\u1ecb B\u1ec7nh Hi\u1ebfm<\/h2>\n<p>Ultragenyx Pharmaceutical \u0111\u1ee9ng \u1edf v\u1ecb tr\u00ed h\u00e0ng \u0111\u1ea7u trong y h\u1ecdc di truy\u1ec1n, chuy\u00ean ph\u00e1t tri\u1ec3n c\u00e1c li\u1ec7u ph\u00e1p cho c\u00e1c b\u1ec7nh di truy\u1ec1n hi\u1ebfm v\u00e0 c\u1ef1c hi\u1ebfm. C\u00e1c s\u1ea3n ph\u1ea9m th\u01b0\u01a1ng m\u1ea1i hi\u1ec7n t\u1ea1i c\u1ee7a c\u00f4ng ty bao g\u1ed3m Crysvita\u00ae cho b\u1ec7nh h\u1ea1 phosphat huy\u1ebft li\u00ean k\u1ebft X, \u0111\u00e3 t\u1ea1o ra 103 tri\u1ec7u USD doanh thu ch\u1ec9 trong qu\u00fd 1 n\u0103m 2025.<\/p>\n<p>Danh m\u1ee5c s\u1ea3n ph\u1ea9m c\u1ee7a c\u00f4ng ty bao g\u1ed3m nhi\u1ec1u li\u1ec7u ph\u00e1p \u0111ang nghi\u00ean c\u1ee9u nh\u1eafm v\u00e0o c\u00e1c b\u1ec7nh nh\u01b0 h\u1ed9i ch\u1ee9ng Sanfilippo, h\u1ed9i ch\u1ee9ng Angelman v\u00e0 b\u1ec7nh d\u1ef1 tr\u1eef glycogen lo\u1ea1i Ia. Ph\u01b0\u01a1ng ph\u00e1p c\u1ee7a h\u1ecd k\u1ebft h\u1ee3p chuy\u00ean m\u00f4n khoa h\u1ecdc s\u00e2u s\u1eafc v\u1edbi s\u1ef1 t\u1eadp trung nh\u00e2n v\u0103n v\u00e0o c\u00e1c b\u1ec7nh \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn nh\u00f3m b\u1ec7nh nh\u00e2n nh\u1ecf nh\u01b0ng c\u00f3 nhu c\u1ea7u y t\u1ebf ch\u01b0a \u0111\u01b0\u1ee3c \u0111\u00e1p \u1ee9ng l\u1edbn.<\/p>\n<p><strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb n\u0103m 2025<\/strong>: Ultragenyx \u0111\u00e3 g\u00e2y ch\u00fa \u00fd khi c\u00f4ng b\u1ed1 r\u1eb1ng b\u1ec7nh nh\u00e2n \u0111i\u1ec1u tr\u1ecb v\u1edbi DTX401 trong c\u00e1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng \u0111\u00e3 gi\u1ea3m \u0111\u00e1ng k\u1ec3 nhu c\u1ea7u tinh b\u1ed9t ng\u00f4 (60-64%) \u0111\u1ebfn m\u1ee9c m\u1ed9t s\u1ed1 ng\u01b0\u1eddi c\u00f3 th\u1ec3 t\u1eadn h\u01b0\u1edfng gi\u1ea5c ng\u1ee7 li\u00ean t\u1ee5c \u0111\u1ea7u ti\u00ean trong nhi\u1ec1u n\u0103m &#8211; m\u1ed9t k\u1ebft qu\u1ea3 \u0111\u01a1n gi\u1ea3n nh\u01b0ng thay \u0111\u1ed5i cu\u1ed9c s\u1ed1ng \u0111\u1ed1i v\u1edbi ng\u01b0\u1eddi m\u1eafc b\u1ec7nh d\u1ef1 tr\u1eef glycogen.<\/p>\n"},"faq":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 b\u1eaft \u0111\u1ea7u \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE)?","answer":"B\u1ea1n n\u00ean ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch uy t\u00edn c\u00f3 cung c\u1ea5p c\u1ed5 phi\u1ebfu NASDAQ, m\u1edf t\u00e0i kho\u1ea3n v\u00e0 n\u1ea1p ti\u1ec1n, sau \u0111\u00f3 nghi\u00ean c\u1ee9u gi\u00e1 hi\u1ec7n t\u1ea1i v\u00e0 \u0111\u1eb7t l\u1ec7nh mua v\u1edbi chi\u1ebfn l\u01b0\u1ee3c ph\u00f9 h\u1ee3p nh\u01b0 s\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1."},{"question":"C\u1ed5 phi\u1ebfu RARE c\u00f3 r\u1ee7i ro g\u00ec c\u1ea7n l\u01b0u \u00fd?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m th\u00e1ch th\u1ee9c ph\u00e1p l\u00fd t\u1eeb FDA, kh\u1ea3 n\u0103ng t\u00e0i ch\u00ednh ch\u01b0a b\u1ec1n v\u1eefng do l\u1ed7 r\u00f2ng l\u1edbn, bi\u1ebfn \u0111\u1ed9ng gi\u00e1 cao v\u00e0 s\u1ef1 ph\u1ee5 thu\u1ed9c v\u00e0o vi\u1ec7c ph\u00ea duy\u1ec7t c\u00e1c li\u1ec7u ph\u00e1p gen trong danh m\u1ee5c."},{"question":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu RARE trong t\u01b0\u01a1ng lai nh\u01b0 th\u1ebf n\u00e0o?","answer":"C\u00e1c nh\u00e0 ph\u00e2n t\u00edch d\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu RARE c\u00f3 th\u1ec3 t\u0103ng l\u00ean m\u1ee9c 48-55 USD v\u00e0o cu\u1ed1i n\u0103m 2025, 65-75 USD n\u0103m 2026, 85-100+ USD n\u0103m 2028 v\u00e0 ti\u1ec1m n\u0103ng \u0111\u1ea1t 120-150+ USD v\u00e0o n\u0103m 2030 d\u1ef1a tr\u00ean ti\u1ebfn tri\u1ec3n s\u1ea3n ph\u1ea9m v\u00e0 doanh thu."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 c\u1ed5 phi\u1ebfu RARE?","answer":"Pocket Option c\u00f3 s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, quy tr\u00ecnh x\u00e1c minh nhanh ch\u00f3ng, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n linh ho\u1ea1t v\u00e0 giao di\u1ec7n th\u00e2n thi\u1ec7n, r\u1ea5t ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi mu\u1ed1n ti\u1ebfp c\u1eadn c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc nh\u01b0 RARE."},{"question":"Ultragenyx Pharmaceutical t\u1eadp trung v\u00e0o l\u0129nh v\u1ef1c n\u00e0o?","answer":"Ultragenyx chuy\u00ean ph\u00e1t tri\u1ec3n c\u00e1c li\u1ec7u ph\u00e1p \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh di truy\u1ec1n hi\u1ebfm v\u00e0 c\u1ef1c hi\u1ebfm, v\u1edbi c\u00e1c s\u1ea3n ph\u1ea9m th\u01b0\u01a1ng m\u1ea1i v\u00e0 nhi\u1ec1u li\u1ec7u ph\u00e1p \u0111ang nghi\u00ean c\u1ee9u nh\u1eb1m \u0111\u00e1p \u1ee9ng nhu c\u1ea7u y t\u1ebf ch\u01b0a \u0111\u01b0\u1ee3c \u0111\u00e1p \u1ee9ng."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 b\u1eaft \u0111\u1ea7u \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE)?","answer":"B\u1ea1n n\u00ean ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch uy t\u00edn c\u00f3 cung c\u1ea5p c\u1ed5 phi\u1ebfu NASDAQ, m\u1edf t\u00e0i kho\u1ea3n v\u00e0 n\u1ea1p ti\u1ec1n, sau \u0111\u00f3 nghi\u00ean c\u1ee9u gi\u00e1 hi\u1ec7n t\u1ea1i v\u00e0 \u0111\u1eb7t l\u1ec7nh mua v\u1edbi chi\u1ebfn l\u01b0\u1ee3c ph\u00f9 h\u1ee3p nh\u01b0 s\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1."},{"question":"C\u1ed5 phi\u1ebfu RARE c\u00f3 r\u1ee7i ro g\u00ec c\u1ea7n l\u01b0u \u00fd?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m th\u00e1ch th\u1ee9c ph\u00e1p l\u00fd t\u1eeb FDA, kh\u1ea3 n\u0103ng t\u00e0i ch\u00ednh ch\u01b0a b\u1ec1n v\u1eefng do l\u1ed7 r\u00f2ng l\u1edbn, bi\u1ebfn \u0111\u1ed9ng gi\u00e1 cao v\u00e0 s\u1ef1 ph\u1ee5 thu\u1ed9c v\u00e0o vi\u1ec7c ph\u00ea duy\u1ec7t c\u00e1c li\u1ec7u ph\u00e1p gen trong danh m\u1ee5c."},{"question":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu RARE trong t\u01b0\u01a1ng lai nh\u01b0 th\u1ebf n\u00e0o?","answer":"C\u00e1c nh\u00e0 ph\u00e2n t\u00edch d\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu RARE c\u00f3 th\u1ec3 t\u0103ng l\u00ean m\u1ee9c 48-55 USD v\u00e0o cu\u1ed1i n\u0103m 2025, 65-75 USD n\u0103m 2026, 85-100+ USD n\u0103m 2028 v\u00e0 ti\u1ec1m n\u0103ng \u0111\u1ea1t 120-150+ USD v\u00e0o n\u0103m 2030 d\u1ef1a tr\u00ean ti\u1ebfn tri\u1ec3n s\u1ea3n ph\u1ea9m v\u00e0 doanh thu."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 c\u1ed5 phi\u1ebfu RARE?","answer":"Pocket Option c\u00f3 s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, quy tr\u00ecnh x\u00e1c minh nhanh ch\u00f3ng, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n linh ho\u1ea1t v\u00e0 giao di\u1ec7n th\u00e2n thi\u1ec7n, r\u1ea5t ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi mu\u1ed1n ti\u1ebfp c\u1eadn c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc nh\u01b0 RARE."},{"question":"Ultragenyx Pharmaceutical t\u1eadp trung v\u00e0o l\u0129nh v\u1ef1c n\u00e0o?","answer":"Ultragenyx chuy\u00ean ph\u00e1t tri\u1ec3n c\u00e1c li\u1ec7u ph\u00e1p \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh di truy\u1ec1n hi\u1ebfm v\u00e0 c\u1ef1c hi\u1ebfm, v\u1edbi c\u00e1c s\u1ea3n ph\u1ea9m th\u01b0\u01a1ng m\u1ea1i v\u00e0 nhi\u1ec1u li\u1ec7u ph\u00e1p \u0111ang nghi\u00ean c\u1ee9u nh\u1eb1m \u0111\u00e1p \u1ee9ng nhu c\u1ea7u y t\u1ebf ch\u01b0a \u0111\u01b0\u1ee3c \u0111\u00e1p \u1ee9ng."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T12:54:57+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE)\",\"datePublished\":\"2025-08-25T12:54:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp\",\"datePublished\":\"2025-08-25T12:54:57+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T12:54:57+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE)","datePublished":"2025-08-25T12:54:57+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp","datePublished":"2025-08-25T12:54:57+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ultragenyx Pharmaceutical Inc. (RARE)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":347775,"slug":"how-to-buy-ultragenyx-pharmaceutical","post_title":"Como comprar a\u00e7\u00f5es da Ultragenyx Pharmaceutical Inc. (RARE) - Investimento em a\u00e7\u00f5es da Ultragenyx Pharmaceutical Inc. (RARE)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-ultragenyx-pharmaceutical\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/347771","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=347771"}],"version-history":[{"count":1,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/347771\/revisions"}],"predecessor-version":[{"id":347773,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/347771\/revisions\/347773"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334090"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=347771"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=347771"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=347771"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}